Skip to main content
. 2022 Nov 11;13:1058819. doi: 10.3389/fimmu.2022.1058819

Figure 2.

Figure 2

Flowchart of identifying patients with metastatic non-small cell lung cancer for grouping of the pre-immunotherapy era and the immunotherapy era.